1. Home
  2. NATR vs GNFT Comparison

NATR vs GNFT Comparison

Compare NATR & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NATR
  • GNFT
  • Stock Information
  • Founded
  • NATR 1972
  • GNFT 1999
  • Country
  • NATR United States
  • GNFT France
  • Employees
  • NATR N/A
  • GNFT 167
  • Industry
  • NATR Biotechnology: Pharmaceutical Preparations
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NATR Health Care
  • GNFT Health Care
  • Exchange
  • NATR Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • NATR N/A
  • GNFT 189.6M
  • IPO Year
  • NATR N/A
  • GNFT 2019
  • Fundamental
  • Price
  • NATR $15.00
  • GNFT $3.80
  • Analyst Decision
  • NATR Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • NATR 2
  • GNFT 1
  • Target Price
  • NATR $19.50
  • GNFT $13.00
  • AVG Volume (30 Days)
  • NATR 42.4K
  • GNFT 9.8K
  • Earning Date
  • NATR 11-07-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • NATR N/A
  • GNFT N/A
  • EPS Growth
  • NATR 114.95
  • GNFT N/A
  • EPS
  • NATR 0.88
  • GNFT 0.47
  • Revenue
  • NATR $445,095,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • NATR $2.07
  • GNFT $155.44
  • Revenue Next Year
  • NATR $2.62
  • GNFT N/A
  • P/E Ratio
  • NATR $17.44
  • GNFT $7.59
  • Revenue Growth
  • NATR 1.36
  • GNFT 175.45
  • 52 Week Low
  • NATR $10.81
  • GNFT $3.31
  • 52 Week High
  • NATR $21.72
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • NATR 42.45
  • GNFT 29.24
  • Support Level
  • NATR $14.90
  • GNFT $3.63
  • Resistance Level
  • NATR $15.88
  • GNFT $3.88
  • Average True Range (ATR)
  • NATR 0.62
  • GNFT 0.10
  • MACD
  • NATR -0.21
  • GNFT 0.02
  • Stochastic Oscillator
  • NATR 5.24
  • GNFT 15.30

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: